Samer Nakhle, M.D.June 30, 2017

FDA 483 - Samer Nakhle, M.D. - June 30, 2017

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

An FDA inspection of Samer Nakhle, M.D. in Las Vegas, NV, a medical research center, identified a significant issue related to the conduct of an investigation. The firm failed to adhere to the investigational plan, specifically regarding subject inclusion criteria. This led to serious consequences, including a subject becoming pregnant and electing to terminate the pregnancy.

Company: Samer Nakhle, M.D.
Inspection Date: June 30, 2017
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West V
Person: Humberto Z. Gomez (investigator)

Open in Dashboard

ID · 2187d1f2-43f7-4e76-96b9-6deb0e6b690a